Adhera Therapeutics.

PositionTRIANGLE: DURHAM

Adhera Therapeutics named Nancy Phelan chief executive officer. She succeeds Robert Moscato Jr., who resigned as CEO and as a board member of the pharmaceutical company last Thursday. Phelan has served as a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT